1. |
We note that you and your subsidiaries intend to operate your business in a manner that will permit you to maintain exemptions from registration under the Investment Company Act of 1940. Please provide us with a
detailed analysis of these exemptions and how your investment strategy will support these exemptions. Further, please note that we will refer your response to the Division of Investment Management for further review.
|
2. |
We note that you intend to operate in a manner that will allow you to qualify as a real estate investment trust. You state on page 59 that you intend to use the net proceeds from the offering to acquire your
target assets in a manner consistent with your investment strategy. It does not appear that you have identified any mortgage-related assets to acquire with a significant portion of the net proceeds of the offering. As a result, your offering
appears to constitute a “blind pool” offering. Accordingly, please tell us how you considered the applicability of Industry Guide 5, or revise to provide the disclosure required by Industry Guide 5. See Securities Act Release 33-6900 (June
17, 1991), Industry Guide 5 and CF Disclosure Guidance: Topic No. 6 for guidance.
|
Loans Expected to Be Funded with Net Proceeds(1)
|
|||
No. of Loans
|
|
|
7
|
Expected Aggregate Principal Amount
|
|
|
$80.0 - $90.0 million
|
Wtd. Average OID Range
|
|
|
2.0% - 6.0%
|
Wtd. Average Cash Interest Rate Range
|
|
|
12.0% - 14.0%
|
Wtd. Average PIK Interest Range
|
|
|
2.0% - 4.0%
|
Percentage of Loans with Floating Rate Interest Range
|
|
|
75.0% - 100.0%
|
Percentage of Loans with Amortization During Term Range
|
|
|
90.0% - 100.0%
|
Percentage of Loans with Prepayment Penalty Range
|
|
|
75.0% - 100.0%
|
Wtd. Average Unused Loan Fee Range
|
|
|
1.0% - 5.0%
|
Wtd. Average YTM IRR Range
|
|
|
17.0% - 25.0%
|
Real Estate Collateral Coverage Range
|
|
|
1.00x - 2.08x
|
(1) |
The above table provides a summary of various unfunded commitments and non-binding term sheets relating to current financing arrangements we intend to fund utilizing proceeds from this offering, subject
to the closing of the loans subject to term sheets. Other than the unfunded commitments to existing borrowers, Public Company C, Private Company A, Private Company B and Private Company C, representing an aggregate principal amount of
approximately $19.8 million, we have not entered into binding definitive commitments relating to these loans. As of December 26, 2020, we have executed non-binding term sheets in connection with three loans representing approximately $62.7
million of anticipated loan commitments and have each entered into a period of exclusivity (ranging from 45 to 60 days) with respect to such proposed loans with two of the three prospective borrowers paying us expense deposits to cover the
direct costs of our due diligence and underwriting process. We are currently completing our underwriting process and negotiating definitive loan documents for each of these three potential loan investments. However, these three potential
loans remain subject to satisfactory completion of our underwriting and due diligence processes, definitive documentation and final approval by the Investment Committee. As a result, no assurance can be given that any of these potential
loans will close on the anticipated terms or at all. If these potential loans do not close, we intend to use the proceeds from this offering to originate and participate in other commercial loans to companies operating in the cannabis
industry that are consistent with our investment strategy, which we would expect to have similar characteristics as the terms reflected in this table. |
|
|
3. |
Please add a summary risk factor to disclose if true, that there is no limit on the amount of leverage you may incur, and also that you may pay distributions from offering proceeds, borrowings, or the sale of
assets to the extent distributions exceed earnings or cash flows from operations.
|
|
• | We may incur significant debt, and our governing documents and current credit facility contain no limit on the amount of debt we may incur. |
|
|
|
|
• | We may in the future pay distributions from sources other than our cash flow from operations, including borrowings, offering proceeds or the sale of assets, which means we will have less funds available for investments or less income-producing assets and your overall return may be reduced. |
|
• | our cash flow from operations may be insufficient to make required payments of principal of and interest on the debt we incur or we may fail to comply with all of the other covenants contained in such debt, which is likely to result in (i) acceleration of such debt (and any other debt containing a cross-default or cross-acceleration provision) that we may be unable to repay from internal funds or to refinance on favorable terms, or at all, (ii) our inability to borrow unused amounts under our financing arrangements, even if we are current in payments on borrowings under those arrangements, and/or (iii) the loss of some or all of our assets to foreclosure or sale; |
|
• | we may be unable to borrow additional funds as needed or on favorable terms, or at all; |
|
• | to the extent we borrow debt that bears interest at variable rates, increases in interest rates could materially increase our interest expense; |
|
• | our default under any loan with cross-default provisions could result in a default on other indebtedness; |
|
• | incurring debt may increase our vulnerability to adverse economic and industry conditions with no assurance that loan yields will increase with higher financing costs; |
|
• | we may be required to dedicate a substantial portion of our cash flow from operations to payments on the debt we may incur, thereby reducing funds available for operations, future business opportunities, stockholder distributions, including distributions currently contemplated or necessary to satisfy the requirements for REIT qualification, or other purposes; and |
|
• | we are not able to refinance debt that matures prior to the loan it was used to finance on favorable terms, or at all. |
4. |
We note your disclosure on page 70 that, in addition to originating loans, you may acquire loans. Additionally, we note your statement on page 25 that your borrowers may incur debt obligations that are senior to
your position. Please revise your disclosure to discuss these aspects of your business.
|
5. |
For each entity that you have loaned money to, please tell us what consideration you gave to disclosing the names of the entities and the states in which they operate, to the extent the information has been
omitted. Additionally, to the extent an entity has an associated PIK interest payment to make, please explain how they intend to pay this interest “in kind.” Please ensure that you define all acronyms where you first use them, such as IRR and
YTM. For loans made for the purposes of construction, please clearly identify those loans and disclose the anticipated completion date(s).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Real Estate
|
|
|
|
|||||||||
Borrower
|
|
|
Date
|
|
|
Our
Total
Commitment
|
|
|
Percentage
of
Total
Portfolio
|
|
|
Total
Funded
Debt
Issuance
|
|
|
Our
Percentage
of the
Total Loan
|
|
|
Estimated
Real
Estate
Value(1)
|
|
|
Real Estate
Collateral
Coverage
|
|
|
Implied Real
Estate
Collateral
|
|
|
Our
Real
Estate
Collateral
Coverage
|
|
|
|
Public Co. A - Real Estate Loan(2)
|
|
|
7/3/2019
|
|
|
$2,940,000
|
|
|
2.6%
|
|
|
$30,000,000
|
|
|
9.8%
|
|
|
$107,000,000
|
|
|
3.57x
|
|
|
$10,486,000
|
|
|
3.57x
|
|
||
Public Co. A - Equipment Loan
|
|
|
8/5/2019
|
|
|
$4,000,000
|
|
|
3.5%
|
|
|
$20,000,000
|
|
|
20.0%
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||
Public Co. B(3)
|
|
|
1/31/2020
|
|
|
$5,000,000
|
|
|
4.4%
|
|
|
$20,000,000
|
|
|
25.0%
|
|
|
$53,100,000
|
|
|
2.66x
|
|
|
$13,275,000
|
|
|
2.66x
|
|
||
Subsidiary of Public Co. C(4)
|
|
|
2/12/2020
|
|
|
$15,000,000
|
|
|
13.3%
|
|
|
$15,000,000
|
|
|
100.0%
|
|
|
$31,178,600
|
|
|
2.08x
|
|
|
$31,178,600
|
|
|
2.08x
|
|
||
Private Co. A(5)
|
|
|
5/8/2020
|
|
|
$34,000,000
|
|
|
30.1%
|
|
|
$42,500,000
|
|
|
80.0%
|
|
|
$51,384,281
|
|
|
1.21x
|
|
|
$41,107,425
|
|
|
1.21x
|
|
||
Private Co. B(6)
|
|
|
9/10/2020
|
|
|
$8,000,000
|
|
|
7.1%
|
|
|
$8,000,000
|
|
|
100.0%
|
|
|
$14,556,107
|
|
|
1.82x
|
|
|
$14,556,107
|
|
|
1.82x
|
|
||
Private Co. C(7)
|
|
|
11/5/2020
|
|
|
$22,000,000
|
|
|
19.5%
|
|
|
$22,000,000
|
|
|
100.0%
|
|
|
$23,733,032
|
|
|
1.08x
|
|
|
$23,733,032
|
|
|
1.08x
|
|
||
Subsidiary of Public Co. D(8)
|
|
|
12/18/2020
|
|
|
$10,000,000
|
|
|
8.9%
|
|
|
$120,000,000
|
|
|
8.3%
|
|
|
$26,058,332
|
|
|
0.22x
|
|
|
$2,171,528
|
|
|
0.22x
|
|
||
Private Co. D(9)
|
|
|
12/23/2020
|
|
|
$12,000,000
|
|
|
10.6%
|
|
|
$12,000,000
|
|
|
100.0%
|
|
|
$7,500,000
|
|
|
0.63x
|
|
|
$7,500,000
|
|
|
0.63x
|
|
||
|
|
|
|
|
|
$112,940,000
|
|
|
100.0%
|
|
|
$289,500,000
|
|
|
39.0%
|
|
|
$314,510,351
|
|
|
1.09x
|
|
|
$144,007,691
|
|
|
1.28x
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
To the extent the applicable loan is intended to fund any acquisitions and/or construction, the applicable figure includes expected total basis on such future construction and/or acquisitions plus appraised value. |
(2) |
Public Company A real estate is based on cost basis. |
(3) |
Public Company B real estate is based on cost basis. |
(4) |
Subsidiary of Public Company C real estate is based on an existing cultivation property and the completed and stabilized value of a to-be-built facility. The anticipated completion date for the to-be-built facility is November 2021. |
(5) |
Private Company A real estate is based on the costs basis of various facilities constituting real estate collateral, plus anticipated capital expenditures for one facility that is being converted for cannabis cultivation purposes. The conversion is anticipated to be completed in February 2021. |
(6) |
Private Company B real estate is based on the expected total cost basis of a to-be-built facility, as completed. The anticipated completion date for the to-be-built facility is July 2021. |
(7) |
Private Company C real estate is based on the cost basis of two facilities, including the capital expenditures for one facility that is being converted for cannabis cultivation purposes. The construction of the to-be-converted facility is divided into six phases. The first phase was completed in December 2020, and the anticipated completion date for the remaining phases of construction is November 2021. |
(8) |
Subsidiary of Public Company D real estate based on total cost basis. |
(9) |
Private Company D real estate is based on appraised value. |
6. |
We note that you have retained Murray Devine as your independent third-party valuation firm. Please file the consent for this firm. Please refer to Section 7(a) and Rule 436 of the Securities Act. Additionally,
we note on page 12 that you refer to a third-party valuation firm that is not identified. Please tell us what consideration you have given to identifying the third party expert and filing its consent.
|
7. |
We note your disclosure that the entities to which you have made loans were considered essential. Please disclose clearly whether Covid-19 has impacted the ability of any of your borrowers to repay their loans in
a timely fashion, and if any have not been able to make timely payments, to the extent material, please quantify the amount they are in arrears and disclose whether you have granted any concessions.
|
8. |
We note your disclosure that you intend to use proceeds from this offering to repay the Revolving Credit Facility. However, your disclosure on page 2 and elsewhere indicates that there are no borrowings
outstanding as of November 15, 2020. Please update your disclosure as appropriate to address this discrepancy.
|
9. |
Please revise your table on page 62 to show the increase in net tangible book value that results from the pro forma transactions separately from the increase attributable to this offering.
|
Assumed initial public offering price per share of our common stock
|
- |
$
|
||||||
Historical net tangible book value per share of our common stock as of September 30, 2020 (on a post-split basis)
|
$
|
15.04
|
- |
|||||
Increase in net tangible book value per share of our common stock attributable to the pro forma transactions
|
$
|
0.05
|
- |
|||||
Increase in net tangible book value per share of our common stock attributable to this offering
|
$ |
- |
||||||
Pro forma as adjusted net tangible book value per share of our common stock, as adjusted to give effect to the pro forma transactions and this offering
|
||||||||
Dilution per share to new investors participating in this offering (1)
|
- |
$
|
(1) |
Dilution is determined by subtracting the pro forma as adjusted net tangible book value per share from the assumed initial public offering price paid by a new investor for a share of our common stock. |
10. |
We note your disclosure that you may terminate your manager for cause upon 30 days prior written notice and we further note clause (v) in the first paragraph in this section. Please add risk factor disclosure
that your manager will remain on for 30 days even if it commits fraud or engages in other criminal activities.
|
11. |
Please provide a summary compensation table. In the table, please ensure that you disclose all fees to be paid to your manager, including, but not limited to, the syndication fee, structuring fee, diligence fee,
monitoring fee, and agency fee. Additionally, please explain the services that the manager will provide in order to receive these fees and how these services are distinct from the services covered under the management fee.
|
|
|
|
For the period from July 31, 2020
(date of commencement of operations)
to September 30, 2020(1)
|
Gross Base Management Fee
|
|
|
$226,234
|
Base Management Fee Rebate(2)(3)
|
|
|
84,167
|
Base Management Fees
|
|
|
$142,067
|
Incentive Compensation(4) |
$- |
(1) |
Does not reflect the amendment to our Management Agreement, which will occur upon consummation of this offering. Upon consummation of this offering, our Management Agreement shall be amended such that
(A) the Base Management Fees (i) shall be in an amount equal to 0.375% of our Equity, determined as of the last day of each quarter, and (ii) will be reduced by only 50% of the aggregate amount of any applicable fees counted toward the Base
Management Fee Rebate; and (B) the Hurdle Amount used in calculating the Incentive Compensation will equal the product of (i) 2% and (ii) Adjusted Capital as of the last day of the immediately preceding fiscal quarter. |
(2) |
For the period from July 31, 2020 (date of commencement of operations) to September 30, 2020, our Base Management Fee was reduced by a Base Management Fee Rebate equal to 100% of the
aggregate amount of any other fees earned and paid to our Manager during the applicable period resulting from the investment advisory services and general management services rendered by it under our Management Agreement, including any
syndication, structuring, diligence, monitoring or agency fees relating to our loans, but excluding the Incentive Compensation. Upon the consummation of this offering, the Management Agreement will be amended such that the Base Management
Fee Rebate will only equal 50% of the aggregate amount of any such fees described in the preceding sentence. |
(3) |
For the period from July 31, 2020 (date of commencement of operations) to September 30, 2020, the Base Management Fee Rebate consisted solely of agency fees charged to our borrowers and paid
to our Manager for its role as agent to the lenders under the applicable credit agreements. We expect that the Base Management Fee Rebate will continue to consist solely of agency fees for the foreseeable future. |
(4) |
Our Manager has agreed to waive the Incentive Compensation for the period from July 31, 2020 (date of commencement of operations) through December 31, 2020. |
12. |
Given the complexity of the incentive fee calculation, please provide a detailed hypothetical example.
|
•
|
Adjusted Capital as of the last day of the immediately preceding fiscal quarter of $100 million; and
|
|
•
|
Core Earnings before the Incentive Compensation for the specified quarter representing a quarterly yield of 20.9% on Adjusted Capital as of the last day of the immediately preceding
fiscal quarter.
|
|
|
|
|
|
|
Illustrative
Amount
|
|
|
Calculation
|
1.
|
|
|
What are the Core Earnings?
|
|
|
$5,225,000
|
|
|
Assumed to be a 5.2% quarterly or 20.9% per annum return on Adjusted Capital as of the last day of the immediately preceding fiscal quarter ($100 million).
|
|
|
|
|
|
|
|
|
|
|
2.
|
|
|
What is the Hurdle Amount?
|
|
|
$2,000,000
|
|
|
The hurdle rate (2.0% quarterly or 8.0% per annum) multiplied by Adjusted Capital as of the last day of the immediately preceding fiscal quarter ($100 million).
|
|
|
|
|
|
|
|
|
|
|
3.
|
|
|
What is the Catch-Up Amount?
|
|
|
$666,667
|
|
|
The catch-up incentive rate (50.0%) multiplied by the amount that Core Earnings ($5.2 million) exceeds the Hurdle Amount ($2 million), but is less than or equal to 166-2/3% of the
Hurdle Amount (approximately $3.3 million).
|
|
|
|
|
|
|
|
|
||
4.
|
|
|
What is the Excess Earnings Amount?
|
|
|
$378,333
|
|
|
The excess earnings incentive rate (20%) multiplied by the amount of Core Earnings ($5.2 million) that exceeds 166-2/3% of the Hurdle Amount (approximately $3.3 million).
|
|
|
|
|
|
|
|
|
|
|
5.
|
|
|
What is the Incentive Compensation?
|
|
|
$1,045,000
|
|
|
The sum of the Catch-Up Amount (approximately $666,667) and the Excess Earnings Amount (approximately $378,333).
|
13. |
Please disclose the natural person or persons who exercise the sole or shared voting and/or dispositive powers with respect to shares held by the entities listed in the table.
|
(2)
|
Gamma Lending Holdco LLC, is a Delaware limited partnership (“GLO”), whose sole General Partner is GRE Lending Opportunities LLC, a Delaware limited liability company
(“GLO GP”). GLO GP is a wholly owned subsidiary of Gamma Real Estate LLC (“GRE”), Jonathan Kalikow owns 50% of the economic and voting interests in GRE and N. Richard Kalikow, father of Jonathan Kalikow, owns the remaining 50% of the
economic and voting interests of GRE.
|
(3)
|
AFCG RM1, LLC, is a Delaware limited liability company and the Manager serves as its manager. Mr. Tannenbaum is the sole manager of the Manager. Pursuant to the terms
of AFCG RM1, LLC’s operating agreement, upon the consummation of this offering, the shares of our common stock held by AFCG RM1, LLC will be promptly distributed to its members and AFCG RM1, LLC will be dissolved. There are approximately 85
members of AFCG RM1, LLC, each of whom beneficially own less than 1% of the shares of our common stock. Mr. Tannenbaum disclaims beneficial ownership of those shares.
|
14. |
We note your disclosure on page 43 and elsewhere that the officers of your manager manage other investment vehicles and that those entities may compete with you for investments. Please add risk factor disclosure
to address the risk of your manager or its officers being internalized or acquired by another entity for which they provide services.
|
15. |
We note your disclosure that certain litigation may only be brought in specific courts in Maryland. Please disclose whether this provision applies to actions arising under the Securities Act or Exchange Act. In
that regard, we note that Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder, and Section 22 of the
Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder. If the provision applies to Securities
Act claims, please also revise your prospectus to state that there is uncertainty as to whether a court would enforce such provision and that investors cannot waive compliance with the federal securities laws and the rules and regulations
thereunder. If this provision does not apply to actions arising under the Securities Act or Exchange Act, please also ensure that the exclusive forum provision in the governing documents states this clearly, or tell us how you will inform
investors in future filings that the provision does not apply to any actions arising under the Securities Act or Exchange Act. Please add risk factor disclosure as appropriate.
|
16. |
In light of your investments in loans collateralized by real estate, please tell us what consideration you gave to providing financial statements and/or a narrative description of the general character of the
properties securing these loans. Reference is made to SAB 1I.
|
17. |
We note you recorded $1.4 million in interest reserves as of September 30, 2020. Please clarify for us how you determined it was appropriate to reflect this item as a liability and to recognize income for this
component. Further, please clarify for us and in your filing how you will record income for this component and tell us your basis for this accounting. Within your response, please reference the authoritative accounting literature management
relied upon.
|
18. |
Please revise to include the disclosures required by ASC 326-20-50 or tell us how you determined such disclosures are not necessary.
|
19. |
We note your footnote disclosure that your management fee is equal to 0.4375% of the Company’s equity. This percentage does not appear to be consistent with the 0.375% disclosed on page 8 of your filing. Please
revise or advise.
|
20. |
We note your disclosure that you may receive the option to assign the right to acquire warrants and/or equity of the borrower. We further note your disclosure that you sold such rights in October and November of
2020. To the extent you held these rights at September 30, 2020, please tell us how you accounted for the rights at September 30, 2020. Within your response, please reference the accounting literature management relied upon.
|
Very truly yours,
|
Respectfully submitted,
|